Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$48.21 USD
-0.09 (-0.19%)
Updated May 28, 2024 04:00 PM ET
After-Market: $48.19 -0.02 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Cytokinetics, Incorporated [CYTK]
Reports for Purchase
Showing records 241 - 260 ( 305 total )
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Omecamtiv mecarbil: a promising new drug in systolic heart failure
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Omecamtiv mecarbil: a promising new drug in systolic heart failure
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Raises $60MM to Fully Fund Phase IIb Study - Updating our Models
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Raises $60MM to Fully Fund Phase IIb Study - Updating our Models
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Another Step Forward: Omecamtiv Progresses to Second Cohort of ATOMIC
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Another Step Forward: Omecamtiv Progresses to Second Cohort of ATOMIC
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Life Sciences: Crowdsourcing AAN: Recap of R&R and Pharm3r Twitter Survey
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Crowdsourcing AAN: Recap of R&R and Pharm3r Twitter Survey
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Life Sciences: Crowdsourcing AAN: Recap of R&R and Pharm3r Twitter Survey
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Cytokinetics, Incorporated
Industry: Medical - Biomedical and Genetics
Encouraging Data Points for ''357 in ALS to Inform Registrational Path
Provider: Roth Capital Partners, Inc.
Analyst: PANTGINIS J